Guidelines and recommendations developed and/or endorsed by the American College of
Rheumatology (ACR) are intended to provide guidance for particular patterns of practice …

The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …

WebMD, and Practice Point communications; and the National Institutes of Health and the
American College of Rheumatology. JAS has received institutional research support from …

Background: The comparative effectiveness of rheumatoid arthritis therapies is uncertain.
Purpose: To compare the benefits and harms of disease-modifying antirheumatic drugs …

Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, and …

Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …

Rheumatoid arthritis (RA) is an autoimmune disorder of unknown etiology characterized by
symmetric, erosive synovitis and, in some cases, extraarticular involvement (1). Most …

Background: Treatment of rheumatoid arthritis (RA) has shifted toward earlier and more
aggressive therapy with traditional disease-modifying antirheumatic drugs (DMARDs) and …

Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …

The WHO/ILAR core set of endpoints for rheumatoid arthritis clinical trials signifies progress
in a continuing worldwide effort. This core set includes the following measures: pain, patient …